The Drug Controller General of India, DCGI has directed drug companies to submit mandatory safety reports of new drugs to it every six months. The country's drug regulator, in it's order, has threatened to cancel drug licenses in case they fail to do so. The Directive came after DCGI found that some companies are not submitting the required mandatory safety reports every six months during the first two years.